A phase 2 study of regorafenib in metastatic/unresectable, refractory synovial sarcomas.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e23551
Abstract: e23551 Background: Current therapeutic options for advanced synovial sarcomas remain limited. Adoptive T-cell therapies against NY-ESO-1 and MAGE-4 benefit a subset of patients, but is of limited value in Asian patients due to the absence… read more here.
Keywords: quality life; sarcomas; synovial sarcomas; median pfs ... See more keywords
Comparative Characterization of Tumor Microenvironments in Monophasic and Biphasic Synovial Sarcomas
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms262010119
Abstract: The impact of histological subtype on immunogenic properties of the tumor microenvironment in synovial sarcomas (SSs) remains understudied. This study aimed to conduct a comparative assessment of tumor microenvironments in monophasic and biphasic SSs. During… read more here.
Keywords: monophasic biphasic; tumor microenvironments; synovial sarcomas; tumor ... See more keywords